Replies to post #223444 on Biotech Values

[biotech_researcher]

A Merck metric that caught my attention:

Keytruda 2018 sales up 88% to $7,171m $MRK $BMY $AZN $RHHBY

[DewDiligence]

MRK 1Q19 items…

PR:
https://s21.q4cdn.com/488056881/files/doc_financials/2019/Merck-News-Release-04-30-19-Merck-Announces-First-Quarter-2019-Financial-Results.pdf

CC slides:
https://investors.merck.com/files/doc_financials/2019/MRK-Q1-2019-Earnings-Presentation.pdf

1Q19 Keytruda sales were $2.27B, +55% YoY and +6% QoQ.

MRK raised 2019 non-GAAP EPS guidance to $4.67-4.79 (from the prior range of $4.57-4.72).